Patent · US Active

Desmoglein 2 (DSG2) binding proteins and uses therefor

US10611803B2 · kind B2 · utility

6Cited by

6References

15Claims

0Family size

Assignee

University of Washington through its Center for Commercialization · US

Inventors

Andre Lieber · Seattle, US
Hongjie Wang · North Logan, US

Key dates

Filing date	Nov 30, 2018
Grant date	Apr 7, 2020
Priority date	—
Expiry date	Nov 30, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.